Drug Safety

What Counts in Data Mining?
pp. 827-832(6)
Authors: Hauben, Manfred; Patadia, Vaishali K.; Goldsmith, David

Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia: Malignant or Maligned?
pp. 833-843(11)
Authors: Herrmann, Nathan; Lanctôt, Krista L.

Disease-Modifying Antirheumatic Drugs in Pregnancy: Current Status and Implications for the Future
pp. 845-863(19)
Authors: Vroom, Fokaline; de Walle, Hermien E.K.; Mart A.J.F van de Laar,; Brouwers, Jacobus R.B.J.; Lolkje T.W. de Jong-van den Berg,

Neuropsychiatric Complications of Antiretroviral Therapy
pp. 865-874(10)
Authors: Cespedes, Michelle S.; Aberg, Judith A.

Comparative Performance of Two Quantitative Safety Signalling Methods: Implications for Use in a Pharmacovigilance Department
pp. 875-887(13)
Authors: Almenoff, June S.; LaCroix, Karol K.; Yuen, Nancy A.; Fram, David; DuMouchel, William

Evidence of Tendinitis Provoked by Fluoroquinolone Treatment: A Case-Control Study
pp. 889-896(8)
Authors: Corrao, Giovanni; Zambon, Antonella; Bertù, Lorenza; Mauri, Anna; Paleari, Valentina; Rossi, Camillo; Venegoni, Mauro

Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine: A Prescription-Event Monitoring Study in England
pp. 897-909(13)
Authors: Layton, Deborah; Wilton, Lynda; Boshier, Andrew; Cornelius, Victoria; Harris, Scott; Shakir, Saad A.W.

ABSTRACTS: ISoP Annual Conference
pp. 911-1010(100)
Author: Adis International Limited,